Most toxicologists aren’t familiar with the acronym ENDS but instantly recognize the terms “vaping device,” “e-cigarette,” or “vape.” According to a recent article published in the New York Times, a total of 1,299 vaping illnesses and 29 deaths associated with ENDS devices have been reported in the United States. The exact cause of these cases is still unknown.
The National Capital Area Regional Chapter of SOT (NCAC-SOT) is holding a Symposium on October 24, 2019, at the National Library of Medicine that is organized around the theme of assessing the toxicity and safety of drugs and devices, including ENDS devices. In the US, ENDS devices are regulated by the US Food and Drug Administration’s Center for Tobacco Products (CTP), which has the authority to review premarket authorizations (PMTAs) for ENDS devices. PMTAs are in the process of being assembled for submission to CTP. The CTP review will entail weighing risks and benefits of such devices and their constituent chemicals upon the population as a whole. Chemical characterization and health risk assessment frameworks for ENDS devices are still undergoing refinement, which underscores the need for transparency and dialogue between regulators and the regulated community.
As part of the day’s activities, the NCAC-SOT Symposium will include speakers from a laboratory that chemically analyzes ENDS devices and their associated e-liquids, as well as a scientist from a leading ENDS device company. The NCAC-SOT welcomes members and nonmembers to this free Symposium, and participation can take place either in person or through remote webinar participation. Please register on the NCAC-SOT website.